PDC Grand Council 2024


Date: Aug 1, 2024 01:00 AM - Aug 3, 2024 01:00 AM

Fee

$0.00

CE Hours

13.00

CE Units

1.300

Registration closes on Sep 03, 2024 01:00 AM

Activity Type

Knowledge

Target Audience(s)

Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
University of Tennessee College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

 

   

Medical Cannabis is widely used in the US; with limited pharmacy programs incorporating cannabis in the curriculum, many pharmacists lack the basic knowledge base of the product which may soon be reclassified as a schedule III drug. Reclassification may lead to even wider use of medical cannabis thereby requiring more pharmacists to have a general working knowledge of the drug.

Objectives

  • Review historical events that impacted medical marijuana use in the United States
  • List FDA approved products and their indications.
  • Identify medical uses, contraindications, monitoring, and dosing parameters of medical marijuana.
  • Review common DDIs.

Speaker(s)/Author(s)

Julie Carter

Activity Number

0064-9999-24-080-L08-P
Date: 08/01/24
Time: 01:00 AM - 01:00 AM

CE Hours

1.50
   

   

This presentation is crucial for pharmaceutical professionals to stay abreast of the latest USP <795> standards, ensuring compliance and upholding the safety and efficacy of non-sterile compounded preparations. It addresses key revisions, guidelines for determining beyond-use dates, and essential aspects of compounding practices, providing necessary knowledge to enhance precision, reduce errors, and maintain quality standards in non-sterile compounding. The presentation is indispensable for ensuring regulatory adherence and promoting best practices in pharmaceutical compounding.
This presentation will enhance current pharmaceutical practices by updating professionals on key revisions in USP <795>, improving their ability to determine accurate beyond-use dates for non-sterile preparations. Additionally, it will elevate practices by providing insights into designing effective training programs, guiding the selection of components based on formulation requirements, and refining mathematical and pharmaceutical calculation skills. These improvements aim to ensure compliance with industry standards, minimize errors, and enhance overall proficiency in non-sterile compounding practices.

Objectives

  • Identify and explain the key revisions and updates in the latest version of USP <795>.
  • Describe and apply guidelines from USP <795> to determine the beyond-use date for non-sterile preparations
  • Identify and justify the selection of components suitable for non-sterile compounding based on formulation requirements.
  • Explain mathematical concepts and pharmaceutical calculations to ensure accurate preparation of non-sterile compound formulations.

Speaker(s)/Author(s)

Omar Allibhai

Activity Number

0064-9999-24-081-L07-P
Date: 08/01/24
Time: 01:00 AM - 01:00 AM

CE Hours

1.50
   

   

The only constant is change. Whether it's guidelines, technology, systems, or other aspects of pharmacy practice, pharmacists are constantly adapting to and effectively communicating change. This activity aims to help pharmacists create a stepwise process for implementing change in their practice and their organizations.

Objectives

  • Identify reasons why change occurs.
  • Identify barriers to effective change
  • Review Kotter's Eight Steps of Change.
  • Apply change management principles to various scenarios
  • Define change management vs change leadership.

Speaker(s)/Author(s)

Ethan Rawl

Activity Number

0064-9999-24-209-L04-P
Date: 08/01/24
Time: 04:00 PM - 05:00 PM

CE Hours

1.50
   

 

   

Student interest in veterinary pharmacy is increasing, and most pharmacy schools don't have a curriculum that includes veterinary pharmacy. Therefore, students are looking for APPE rotation opportunities to explore what veterinary pharmacy is all about. Pharmacists/preceptors need to be educated and prepared to offer a rotation that can provide the basic information necessary to prepare a student to fill a prescription safely and accurately for an animal patient. This presentation is meant to guide a pharmacist/preceptor on what basic concepts need to be included in an effective and meaningful veterinary pharmacy APPE rotation
To allow the conference participants to meet several of the unique species at the Indianapolis Zoo (e.g., megavertebrates, marine mammals). This will allow the audience to truly appreciate the anatomical & environmental challenges that zoo veterinarians face on a daily basis when working with these species. Pharmacological challenges specific to each species will be discussed during the tour, including the necessity for extra-label drug use and compounded medications.

Objectives

  • Describe the basic components necessary for a meaningful veterinary pharmacy APPE rotation
  • Identify resources for the pharmacist/preceptor and students to access during the rotation and in practice.
  • Review components of a veterinary pharmacy APPE rotation that have been successful with pharmacists/preceptors who are currently providing approved APPE rotations.

Speaker(s)/Author(s)

Thomas Magnifico

Activity Number

0064-9999-24-083-L01-P
Date: 08/02/24
Time: 04:00 PM - 05:00 PM

CE Hours

1.50
   

   

Medication safety is a common workhorse in all our roles in pharmacists regardless of clinical practice setting. Pediatric patients are a sub-specialty group that is more prone to adverse medication events. There are 7.5 million preventable pediatric medication errors annually in the US - 31% incidence of medication errors in pediatric patients compared to 13% in adult patients. The purpose of this knowledge-based activity is to review medication safety and specific considerations in pediatric patients as well as application of KIDS list in clinical practice

Objectives

  • Recognize the evolution in timeline of patient safety
  • Review the pros/cons of technology in health care.
  • Describe how unique characteristics of pediatric patients make them more susceptible to adverse drug events.
  • Review the purpose of the KIDs and limitation in utilization as clinical reference tool
  • Identify how the KIDS list can be implemented and review the current process of KIDS list implementation on hospital enterprise level.

Speaker(s)/Author(s)

Dimitrios Savva, PharmD, BCPPS

Activity Number

0064-9999-24-084-L05-P
Date: 08/02/24
Time: 01:00 AM - 01:00 AM

CE Hours

1.50
   

   

Managed care organizations and pharmacy benefit managers utilize multiple tools and practices, including prior authorizations, to optimize patient outcomes and reduce waste, error, unnecessary drug use, and cost. These often must follow Centers for Medicare & Medicaid Services (CMS) guidelines if they are Medicare plan sponsors. However, this can often lead to delays in treatments for patients and unsatisfactory reimbursement for community pharmacies. Increased knowledge of the prior authorization process and other PBM practices can allow pharmacists to understand the complex processes of PBMs. The purpose of this knowledge-based activity is to explain the prior authorization process and explore the current landscape of the relationships between PBMs and community pharmacies

Objectives

  • Paraphrase the current landscape of PBMs and insurers in the United States.
  • Explain the prior authorization process for Medicare plan sponsors.
  • Describe the impact PBMs have on community pharmacies.

Speaker(s)/Author(s)

Jennifer Brown

Rachel Whitesitt

Activity Number

0064-9999-24-085-L04-P
Date: 08/02/24
Time: 01:00 AM - 01:00 AM

CE Hours

1.00
   

 

   

There have been new medications approved for a study for Alzheimer's disease (AD) that may cause confusion on its efficacy, side effects, and overall utility. These classes of medications include the immunoglobulin gamma 1 (IgG1) agents. Additionally, newer treatments are available for comorbid psychiatric conditions for AD. Additionally, new options for the treatment of major depressive disorder have been approved and being currently studied. These agents include but are not limited to esketamine and psilocybin. Pharmacists need to be aware of the potential benefits, side effects, and counseling points to provide patients using these medications. Therefore, knowledge of evidence-based treatment options is critical for pharmacists to assist patients in their treatment. The purpose of this knowledge-based activity is to review the medications available and their effectiveness as well as discuss the limitations of their treatment options

Objectives

  • Explain standard and newer treatment options for cognitive disorders for Alzheimer's disease
  • Recognize preferred treatments for managing comorbid psychiatric issues in patients with cognitive disease.
  • Describe how to counsel caregivers and patients regarding treatment options for cognitive disorders.
  • Describe the pharmacologic properties and role of newer antidepressants.
  • Explain the utility of psilocybin in depression

Speaker(s)/Author(s)

Joshua Caballero

Activity Number

0064-9999-24-086-L01-P
Date: 08/03/24
Time: 01:00 AM - 01:00 AM

CE Hours

1.00
   

   

The pandemic changed the delivery of pharmacy education.  In preparing our future pharmacists to be self-directed learners, it is critical to embrace active learning to improve long-term retention and application of knowledge prior to clinical rotations.  This activity will help participants identify and implement active learning strategies in the classroom

Objectives

  • Identify 3 different learning activities that can be utilized in classroom learning.
  • Describe active learning strategies to various classroom topics

Speaker(s)/Author(s)

Thomas (TJ) Frail

Activity Number

0064-9999-24-087-L04-P
Date: 08/03/24
Time: 01:00 AM - 01:00 AM

CE Hours

1.50
   

   

This lecture will provide an overview of the most recent literature regarding migraine headaches. I will provide a deep dive into the diagnosis, prevention, and treatment of this disease state.  The presentation will close with patient cases drawn from my own practice with particular attention provided to care available in various healthcare settings

Objectives

  • Discuss and explain the differences and overall treatment strategies between specific types of migraine headaches.
  • Review and apply treatment options available to prevent a migraine headache.
  • Review and apply abortive options available to treat a migraine headache.
  • Review and recommend, given a patient case, treatment to manage migraine patients in different healthcare settings

Speaker(s)/Author(s)

Sejal Patel-Francis

Activity Number

0064-9999-24-088-L01-P
Date: 08/03/24
Time: 01:00 AM - 01:00 AM

CE Hours

1.00
   

   

The body of literature is continually growing, and it is important for pharmacists to keep updated with the latest research and evidence.  This program is designed to update pharmacists with new information related to cardiology (atrial fibrillation and heart failure with preserved ejection fraction).

Objectives

  • Compare outcomes for rate vs rhythm control in patients with A.Fib.
  • Recognize new methods of assessing stroke and bleeding risk in patients with A.Fib.
  • Describe the outcomes of studies involving SGLT2 Inhibitors in the treatment of HFpEF.
  • Describe the outcomes of studies involving GLP-1 Agonists in the treatment of HFpEF.

Speaker(s)/Author(s)

Jennifer Polyniak

Activity Number

0064-9999-24-089-L01-P
Date: 08/03/24
Time: 01:00 AM - 01:00 AM

CE Hours

1.00